Non-Dilutive Capital: The Secret Weapon for Deep Tech Founders.

Deep tech takes time. Quantum, semiconductors, and biotech require long R&D cycles that don't always align with the 'blitzscale' pressure of traditional VC.

The Equity Trap

Founders often raise early dilutive rounds just to cover basic laboratory or engineering costs. By the time they hit Series A, they've often given away 30-40% of their company. There is a better way.

Leveraging Subsidies

Through our partnership with Holland High Tech and our GRNTS.app platform, we help technical founders access the €2B+ of non-dilutive capital available in Europe. This 'free' money allows you to hit milestones that significantly increase your valuation before you ever talk to an angel or VC.

If you are building in one of the HTSM domains, you are sitting on a goldmine of capital that doesn't cost you a single share.